WELLS FARGO & COMPANY/MN - CYMABAY THERAPEUTICS INC ownership

CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 194 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of CYMABAY THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$307,474
-31.3%
20,622
-49.6%
0.00%
Q2 2023$447,647
+8194.4%
40,881
+6504.4%
0.00%
Q1 2023$5,397
+60.3%
619
+15.3%
0.00%
Q4 2022$3,367
+12.2%
537
-23.2%
0.00%
Q3 2022$3,0000.0%699
-1.4%
0.00%
Q2 2022$3,000
-90.3%
709
-92.8%
0.00%
Q1 2022$31,000
-70.5%
9,859
-68.2%
0.00%
Q4 2021$105,000
+556.2%
30,981
+638.2%
0.00%
Q3 2021$16,000
-91.8%
4,197
-90.5%
0.00%
Q2 2021$194,000
-81.0%
44,324
-80.3%
0.00%
Q1 2021$1,021,000
-1.5%
224,942
+24.4%
0.00%
Q4 2020$1,037,000
+181.0%
180,781
+254.3%
0.00%
Q3 2020$369,000
+64.7%
51,023
-20.4%
0.00%
Q2 2020$224,000
+234.3%
64,090
+41.5%
0.00%
Q1 2020$67,000
-29.5%
45,308
-6.4%
0.00%
Q4 2019$95,000
-78.7%
48,397
-44.4%
0.00%
Q3 2019$446,000
-11.5%
87,053
+23.6%
0.00%
Q2 2019$504,000
-72.9%
70,458
-49.6%
0.00%
-100.0%
Q1 2019$1,858,000
+66.5%
139,935
-1.4%
0.00%
Q4 2018$1,116,000
-26.9%
141,856
+2.9%
0.00%
Q3 2018$1,527,000
+23.8%
137,793
+50.0%
0.00%
Q2 2018$1,233,000
+80.0%
91,864
+74.2%
0.00%
Q1 2018$685,000
+90.3%
52,723
+34.7%
0.00%
Q4 2017$360,000
+8900.0%
39,146
+7729.2%
0.00%
Q3 2017$4,0005000.00%
Other shareholders
CYMABAY THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 1,653,495$10,367,4148.97%
Versant Venture Management, LLC 543,753$3,409,3307.06%
TCG Crossover Management, LLC 5,905,400$37,026,8586.54%
COMMODORE CAPITAL LP 5,738,500$35,9805.42%
Foresite Capital Management IV, LLC 1,787,094$11,205,0794.79%
Saturn V Capital Management LP 1,611,778$5,718,4324.74%
ACUTA CAPITAL PARTNERS, LLC 1,015,000$6,364,0503.92%
Altium Capital Management LP 1,025,000$6,426,7503.27%
Affinity Asset Advisors, LLC 1,143,531$7,169,9392.81%
GREAT POINT PARTNERS LLC 1,550,000$9,718,5001.90%
View complete list of CYMABAY THERAPEUTICS INC shareholders